Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,241 | -34,005 | -23,332 | -11,580 | -5,995 |
| Depreciation Amortization | 699 | 574 | 428 | 232 | 786 |
| Accounts receivable | -507 | -276 | -3 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,902 | -1,133 | -602 | 1,443 | 1,019 |
| Other Working Capital | -3,236 | -2,194 | -1,491 | 1,236 | 1,909 |
| Other Operating Activity | 11,472 | 7,175 | 3,566 | -118 | -32,497 |
| Operating Cash Flow | $-36,715 | $-29,859 | $-21,434 | $-8,787 | $-34,778 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,565 | 23,559 | 20,088 | 4,846 | 44,845 |
| PPE Investments | -5 | N/A | N/A | N/A | -76 |
| Investing Cash Flow | $21,560 | $23,559 | $20,088 | $4,846 | $44,769 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 62,158 | 62,140 | 43,806 | 32,590 | 1,310 |
| Financing Cash Flow | $62,158 | $62,140 | $43,806 | $32,590 | $1,310 |
| Beginning Cash Position | 16,455 | 16,455 | 16,455 | 16,455 | 5,154 |
| End Cash Position | 63,458 | 72,295 | 58,915 | 45,104 | 16,455 |
| Net Cash Flow | $47,003 | $55,840 | $42,460 | $28,649 | $11,301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,715 | -29,859 | -21,434 | -8,787 | -34,778 |
| Capital Expenditure | -5 | N/A | N/A | N/A | -76 |
| Free Cash Flow | -36,720 | -29,859 | -21,434 | -8,787 | -34,854 |